BAYN.DE - Bayer Aktiengesellschaft

XETRA - XETRA Delayed Price. Currency in EUR
59.30
-1.98 (-3.23%)
At close: 5:35PM CET
Stock chart is not supported by your current browser
Previous Close61.28
Open61.10
Bid0.00 x 28400
Ask0.00 x 2100
Day's Range59.20 - 61.48
52 Week Range58.34 - 103.74
Volume5,107,733
Avg. Volume2,934,667
Market Cap55.464B
Beta (3Y Monthly)0.89
PE Ratio (TTM)32.94
EPS (TTM)1.80
Earnings DateApr 25, 2019
Forward Dividend & Yield2.80 (4.57%)
Ex-Dividend Date2019-04-29
1y Target Est120.99
  • Bayer struggles to quell investor worries after second major legal setback
    Yahoo Finance Video4 days ago

    Bayer struggles to quell investor worries after second major legal setback

    Pharmaceutical giant Bayer faced yet another legal setback, after a San Francisco jury concluded that the company's popular weedkiller, Roundup, triggered a man's Hodgkin's lymphoma. News of the court loss caused shares to plunge on Wednesday, and investors - many of whom were wary of Bayer's initial acquisition of agricultural giant, Monsanto - are more concerned than ever before. Yahoo Finance's Sibile Marcellus has the latest.

  • Cancer case verdict causes Bayer's stock to fall
    Yahoo Finance Video4 days ago

    Cancer case verdict causes Bayer's stock to fall

    Bayer stock is takes a big hit as the company deals with the ruling on a lawsuit saying its "Roundup Weed Killer" causes cancer. Girard CIO Timothy Chubb joins Yahoo Finance's Julie Hyman, Adam Shapiro, and Scott Gamm to discuss.

  • Bayer slides after losing cancer case
    Yahoo Finance Video4 days ago

    Bayer slides after losing cancer case

    Yahoo Finance’s Alanna Petroff weighs in on what’s happening in the overseas markets.

  • Bayer shares slide after latest Roundup cancer ruling
    Reuters Videos4 days ago

    Bayer shares slide after latest Roundup cancer ruling

    Shares in Germany's Bayer's fell more than 12 percent on Wednesday after a second U.S. jury ruled its Roundup weed killer caused cancer. Francis Maguire reports.

  • Reuters2 hours ago

    Bayer CEO says his team retains backing of supervisory board: report

    Bayer's management retains the backing of its supervisory board, its chief executive said, after pressure on the company increased when a second jury in the United States ruled its glyphosate-based Roundup weed killer caused cancer. Bayer, which denies allegations that glyphosate or Roundup cause cancer, acquired Monsanto, the maker of Roundup, for $63 billion last year. "The share price is significantly impacted by the legal cases related to glyphosate in America, the discounts are greatly exaggerated," Chief Executive Werner Baumann told Frankfurter Allgemeine Sonntagszeitung (FAS).

  • Reuters4 hours ago

    Bayer CEO says his team retains backing of supervisory board - report

    Bayer's management retains the backing of its supervisory board, its chief executive said, after pressure on the company increased when a second jury in the United States ruled its glyphosate-based Roundup weed killer caused cancer. Bayer, which denies allegations that glyphosate or Roundup cause cancer, acquired Monsanto, the maker of Roundup, for $63 billion (£47.68 billion) last year. "The share price is significantly impacted by the legal cases related to glyphosate in America, the discounts are greatly exaggerated," Chief Executive Werner Baumann told Frankfurter Allgemeine Sonntagszeitung (FAS).

  • Barrons.com2 days ago

    Bayer’s Deal for Monsanto Looked Like a Winner. Now It Looks Like a Lesson in How Not to Do M&A

    The German chemical and pharma giant was fading and made a play for a hot U.S. seed and ag chemicals company. Bayer won Monsanto, but made nearly every mistake in the M&A playbook.

  • Bloomberg2 days ago

    For Bayer and FedEx, Deal Hindsight is 20/20

    Both deals were the companies’ largest.First, Bayer. A second U.S. jury this week linked Monsanto’s Roundup weed killer to cancer, crystallizing the likelihood that Bayer will face substantial legal liabilities as it battles some 11,200 outstanding lawsuits.

  • Roundup Judge Loosens His Grip on Monsanto Ghosts Haunting Bayer
    Bloomberg3 days ago

    Roundup Judge Loosens His Grip on Monsanto Ghosts Haunting Bayer

    U.S. District Judge Vince Chhabria has maintained a white-knuckle grip on the case, and has kept lawyers suing Bayer on an especially tight leash -- until now. In rulings before and during the first part of a trial in San Francisco federal court, the judge tossed witnesses and whittled evidence offered up by lawyers representing Ed Hardeman, one of more than 11,200 people in the U.S. suing Bayer over claims exposure to Roundup caused their cancer. When Hardeman’s lead lawyer strayed too far from his rules during her opening presentation, Chhabria sanctioned her and confiscated offending slides she had planned to show the jury.

  • Financial Times3 days ago

    [$$] Monsanto risk takes root with Bayer investors

    Bayer insists that glyphosate-based weedkillers like its Roundup and Ranger Pro products pose no health risk to the farm workers and gardeners who use them around the world. For one particular group of people, however, the substance has proven highly toxic: Bayer’s own shareholders. ordered Bayer to pay $289m in damages in a similar case, the group’s shares have fallen by more than a third — wiping almost €25bn from its market value.

  • Jury finding upends Bayer's Roundup defense strategy: experts
    Reuters4 days ago

    Jury finding upends Bayer's Roundup defense strategy: experts

    Bayer AG had hoped a new trial strategy focusing jurors on scientific evidence could stem a burgeoning tide of U.S. lawsuits over its glyphosate-based weed killer Roundup, but a second jury finding on Tuesday that the product caused cancer has narrowed the company's options, some legal experts said. Bayer shares tumbled more than 12 percent on Wednesday after a unanimous jury in San Francisco federal court found Roundup to be a "substantial factor" in causing California resident Edwin Hardeman's non-Hodgkin's lymphoma. The jury decision was a blow to Bayer after the judge in the Hardeman case, at the company's request, had split the trial, severely limiting evidence plaintiffs could present in the first phase.

  • The Wall Street Journal4 days ago

    [$$] Bayer Shares Fall After Legal Setback on Roundup Weedkiller

    The verdict shows how the German company’s $63 billion acquisition of U.S. agriculture giant Monsanto Co.—which was designed to bolster Bayer’s fading fortunes—has now become its biggest potential liability. Bayer needs the tide to turn in its favor both to avoid what analysts fear could be billions in potential legal damages and to convince investors that its Monsanto bet was right. Bayer has said the extent of the litigation it now faces wasn’t foreseeable at the time of the Monsanto deal, which turned the inventor of aspirin into the world’s largest maker of seeds and pesticides.

  • Reuters4 days ago

    Jury finding upends Bayer's Roundup defence strategy: experts

    Bayer AG had hoped a new trial strategy focusing jurors on scientific evidence could stem a burgeoning tide of U.S. lawsuits over its glyphosate-based weed killer Roundup, but a second jury finding on Tuesday that the product caused cancer has narrowed the company's options, some legal experts said. Bayer shares tumbled more than 12 percent on Wednesday after a unanimous jury in San Francisco federal court found Roundup to be a "substantial factor" in causing California resident Edwin Hardeman's non-Hodgkin's lymphoma. The jury decision was a blow to Bayer after the judge in the Hardeman case, at the company's request, had split the trial, severely limiting evidence plaintiffs could present in the first phase.

  • Bloomberg4 days ago

    There's No Proof Roundup Causes Cancer But Questions Linger

    Regulators in the U.S., European Union and elsewhere have said it probably isn’t a carcinogen, and more than 800 studies back that up, including an epidemiological study undertaken by the National Cancer Institute that found glyphosate use wasn’t associated with overall cancer risk. Tina Levine, a former director of the Health Effects Division of the Office of Pesticide Programs in the U.S. Environmental Protection Agency, said human health concerns were minimal.

  • Bayer Stock Tumbles After Jury Finds Weed-Killer Roundup Caused Cancer
    Investor's Business Daily4 days ago

    Bayer Stock Tumbles After Jury Finds Weed-Killer Roundup Caused Cancer

    The market cap for Germany's Bayer shrank by more than $6 billion Wednesday after a jury said its Roundup weed killer caused cancer. Now, jurors must determine liability and damages.

  • Shares in Germany's Bayer plunge on US weed killer ruling
    Associated Press4 days ago

    Shares in Germany's Bayer plunge on US weed killer ruling

    BERLIN (AP) — Shares in chemicals manufacturer Bayer fell sharply Wednesday after a U.S. jury found the Roundup weed killer to have been a substantial factor in a California man's cancer.

  • Benzinga4 days ago

    Bayer's Legal Woes Mount As Jury Again Links Roundup To Cancer

    Roundup, a broad-spectrum, glyphosate-based herbicide, came into Bayer's fold with its June 2018 acquisition of U.S. agrochemical company Monsanto for $62.5 billion. Exposure to herbicides with glyphosate as an active ingredient increases the risk of cancer in those exposed by 41 percent, according to a research article published in ScienceDirect. The San Francisco jury's preliminary verdict comes after a California state court awarded $289 million in damages to a school groundskeeper in August 2018.

  • U.S. jury hears more evidence as second phase of Roundup cancer trial begins
    Reuters4 days ago

    U.S. jury hears more evidence as second phase of Roundup cancer trial begins

    A lawyer for a man who sued Bayer AG unit Monsanto after developing cancer on Wednesday told a jury about the company's alleged efforts to influence scientists and regulators, a day after the jury found Bayer's glyphosate-based weed killer Roundup to have caused the man's disease. The jury in San Francisco federal court on Tuesday found Roundup to be a "substantial factor" in causing California resident Edwin Hardeman's non-Hodgkin's lymphoma, but did not find Bayer liable.

  • Barrons.com4 days ago

    Bayer’s Latest Legal Setback Spooks Financial Markets

    Bayer‘s liabilities could grow after a West Coast jury finds that the German company’s weedkiller likely triggered cancer.

  • Reuters4 days ago

    European stocks break 5-day rally; Bayer, BMW weigh on DAX

    The pan-European STOXX 600 index fell 0.9 percent as investors booked profits after five sessions of gains, with Bayer's near 10 percent slump weighing the most. Bayer's tumble came after a San Francisco jury became the second to rule against Bayer's Roundup, which was added to its products after the acquisition of Monsanto last year.

  • The Wall Street Journal4 days ago

    [$$] Bayer Shareholders Face the Lawyers

    Investors are once again faced with a very modern investing problem: how to grapple with the power of U.S. civil courts. This is Bayer’s latest setback since acquiring biotech seed company Monsanto for $63 billion last June. shares plunged in December after fresh concerns over legal liability from its iconic baby powder, though the stock has recovered since then.

  • Bayer's Blind Spot on Monsanto's Roundup May Cost Billions
    Bloomberg4 days ago

    Bayer's Blind Spot on Monsanto's Roundup May Cost Billions

    Bayer says science shows that the herbicide, which the German company gained in its $63 billion acquisition of Monsanto Co., is safe. Now that a second U.S. jury has linked the product to cancer, the uphill battle Chief Executive Officer Werner Baumann is fighting just got steeper. Roundup became the company’s leading headache after the June 7 completion of the Monsanto deal that Baumann entered to remain a global competitor in seeds and agricultural products.